PMGC Holdings Inc. (ELAB)
NASDAQ: ELAB · Real-Time Price · USD
2.360
+0.070 (3.06%)
At close: Jul 18, 2025, 4:00 PM
2.370
+0.010 (0.42%)
Pre-market: Jul 21, 2025, 8:20 AM EDT
PMGC Holdings Employees
As of December 31, 2024, PMGC Holdings had 3 total employees, including 2 full-time and 1 part-time employees. The number of employees decreased by 15 or -83.33% compared to the previous year.
Employees
3
Change (1Y)
-15
Growth (1Y)
-83.33%
Revenue / Employee
n/a
Profits / Employee
-$2,152,314
Market Cap
3.25M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3 | -15 | -83.33% |
| Dec 31, 2023 | 18 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
ELAB News
- 2 days ago - PMGC Holdings Inc. Completes Acquisition of CNC Machining Company - AGA Precision Systems LLC - GlobeNewsWire
- 11 days ago - PMGC Holdings Inc. Completes Acquisition of Custom IT Packaging Company Pacific Sun Packaging with Over $2,000,000 in Combined Revenue for Fiscal Years 2023 and 2024 - GlobeNewsWire
- 27 days ago - PMGC Holdings Inc. Signs Non-Binding LOI to Acquire CNC Aerospace Manufacturer Generating $4.5 Million in Annual Revenue - GlobeNewsWire
- 4 weeks ago - PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies - GlobeNewsWire
- 4 weeks ago - Northstrive Biosciences Announces Initiation of Phase II of Collaboration to Develop AI Powered Therapies for Obesity and Cardiometabolic Diseases - GlobeNewsWire
- 5 weeks ago - PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based AS9100D & ISO 9001:2015 Certified CNC Machine Shop Serving Aerospace, Defense, and Industrial Markets for over 35 years - GlobeNewsWire
- 6 weeks ago - PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Electronics Manufacturing Company - GlobeNewsWire
- 2 months ago - NorthStrive Biosciences Announces Completion of Phase I Strategic Review for EL-22 Targeting Muscle Loss Associated with GLP-1 Weight Loss Drugs and Age-Related Sarcopenia - GlobeNewsWire